Research and Development Team
Cangjing Yang, Ph.D.
Senior Vice President, Industrialization

Dr. Yang received his Ph.D. degree in Genetics from the School of Life Sciences, Fudan University. With solid experience in hormone signaling transduction pathways and four published SCI papers, Dr. Yang leads the company’s pre-clinical research of oncotherapy drugs and industrialization projects for Zensun’s drugs & medical devices.

Qinghe Lok, Ph.D.
Deputy Vice President, Preclinical Pharmacology Research
Dr. Lok received his Ph.D. in neuropharmacology from Shanghai Jiaotong University in 2014. From June 2006 to June 2007, he worked as a chemist at Chemlab (Malaysia). From May 2014 to May 2016, he was a postdoctoral fellow in the department of biology (neurology) of Shanghai Jiaotong University. He joined Zesun in 2016, currently serving as Deputy Vice President of the pharmaceutical department, responsible for the preclinical pharmacology research of new drugs.
Wenfeng Wang, Ph.D.
Director, Small Molecular Drugs R&D
Dr. Wenfeng Wang earned his Ph.D. in Applied Chemistry from East China University of Science and Technology in 2011. He joined Zensun as Director of R&D department, and took the responsibility of CMC for small molecular drugs. Before joining Zensun, he served as drug development manager for formulation, in Shanghai Haini Pharmaceutical Co., Ltd of Yangtze River Pharmaceutical Group. He has more than 6-year industrial experience in pharmaceutical companies and is familiar with regulatory affairs and IND/NDA filing.
Bo Zhao, Ph.D.
Director, Manufacturing
Dr. Zhao obtained his Ph.D. degree at Shanghai Institute of Pharmaceutical Industry (SIPI) majored in Microbiology and Biochemical Pharmacy. He joined Zensun in 2013, where he works as group leader of Production Department, and Jinshan factory. Now he is taking responsibility for optimization of process, new proteins scale-up, and industry base of Neucardin.
Zhefeng Cai, Ph.D.
Director, Intellectual Property
Mr. Cai earned his Ph.D. degree in medicinal chemistry from Institute of Materia Medica, Peking Union Medical College (PUMC). Zhefeng has solid experience in drug research, medical information and intellectual property management. Now he focuses on Zensun’s intellectual property and business cooperation.
 
Clinical Trials Recruiting Participants